(NASDAQ: BHST) Bioharvest Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.94%.
Bioharvest Sciences's revenue in 2025 is N/A.On average, 2 Wall Street analysts forecast BHST's revenue for 2025 to be $728,977,012, with the lowest BHST revenue forecast at $700,039,726, and the highest BHST revenue forecast at $757,914,298. On average, 2 Wall Street analysts forecast BHST's revenue for 2026 to be $1,207,828,444, with the lowest BHST revenue forecast at $1,026,147,342, and the highest BHST revenue forecast at $1,389,509,546.
In 2027, BHST is forecast to generate $1,490,530,130 in revenue, with the lowest revenue forecast at $1,490,530,130 and the highest revenue forecast at $1,490,530,130.